MedPath

ACD-A

Anticoagulant Citrate Dextrose Solution, USP (ACD), Solution A

Approved
Approval ID

ec28b740-2fd1-453e-9ee9-1aa20d223d6c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 9, 2015

Manufacturers
FDA

Haemonetics Manufacturing Inc

DUNS: 078598396

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Anticoagulant Citrate Dextrose Solution A

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53157-796
Application NumberNDA710497
Product Classification
M
Marketing Category
C73594
G
Generic Name
Anticoagulant Citrate Dextrose Solution A
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 9, 2015
FDA Product Classification

INGREDIENTS (3)

SODIUM CITRATEActive
Quantity: 2.20 g in 100 mL
Code: 1Q73Q2JULR
Classification: ACTIB
DEXTROSE MONOHYDRATEActive
Quantity: 2.45 g in 100 mL
Code: LX22YL083G
Classification: ACTIB
CITRIC ACID MONOHYDRATEActive
Quantity: 0.73 g in 100 mL
Code: 2968PHW8QP
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACD-A - FDA Drug Approval Details